Search 33,000+ CME courses
Back

StatPearls, LLC

  • Acetylcholine
  • Cholinergic Antagonists
  • Spasm
  • Urinary Bladder, Neurogenic
  • Urinary Bladder, Overactive

Oxybutynin

Oxybutynin, an anticholinergic medication, is approved by the U.S. Food and Drug Administration (FDA) and is indicated for patients with overactive bladder or symptoms of detrusor overactivity, such as urinary frequency and urgency. Oxybutynin works through competitive acetylcholine antagonism at postganglionic muscarinic receptors, leading to the relaxation of the smooth muscles of the bladder. This medication has been thoroughly researched and approved for use in patients aged 5 and older. In addition, oxybutynin is recommended for individuals who experience detrusor instability due to neurogenic bladder. In certain cases, oxybutynin may be used to control bladder spasms triggered by indwelling ureteral stents or Foley catheters. This activity provides a comprehensive overview of oxybutynin’s indications, mechanism of action, methods of administration, significant adverse effects, contraindications, monitoring, and toxicity. The activity also aims to equip the interprofessional healthcare team by enhancing their competence to direct patient therapy effectively, particularly when anticholinergic treatment is warranted for patients with overactive bladder.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 1.5 creditsAAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

ABS — Accredited CMEUp to 1.5 pointsABPATH — Lifelong LearningUp to 1.5 pointsABTS — Accredited CMEUp to 1.5 pointsABIM — Medical KnowledgeUp to 1.5 pointsABS — Self-AssessmentUp to 1.5 pointsABP — Lifelong Learning and Self-AssessmentUp to 1.5 pointsABTS — Self-AssessmentUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 6 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left

More from StatPearls, LLC

See all

This provider’s courses closest to this one

More in Urology

See all

Courses from other providers in this specialty